Evidence map›Paper›PMID 18702528›Full record

ArticleBiochemistry2008

Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor?

Andrew J Beel, Charles K Mobley, Hak Jun Kim, Fang Tian, Arina Hadziselimovic, Bing Jap, James H Prestegard, Charles R Sanders

Abstract read
In one paragraph

Article in Biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 175 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.Journal of Alzheimer's disease : JAD · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Formation of extramembraneProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Andrew J BeelDepartment of Biochemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee 37232-8725, USA.
Charles K Mobley
Hak Jun Kim
Fang Tian
Arina Hadziselimovic
Bing Jap
James H Prestegard
Charles R Sanders
Lawrence Berkeley National Laboratory · USVanderbilt University · USUniversity of Georgia · US

Funding

MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Protein Structure and Dynamics from EPR Spectroscopy and MD SimulationsP01GM080513 · NIGMS · VANDERBILT UNIVERSITY · PI LYBRAND, TERRY P · 2008 to 2012
$5.6M
Southeast Collaboratory for High-Field Biomolecular NMRP41GM066340 · NIGMS · UNIVERSITY OF GEORGIA (UGA) · PI PRESTEGARD, JAMES H · 2002 to 2006
$5.5M
FAD Mutations in the Amyloid Precursor ProteinR21AG026581 · NIA · VANDERBILT UNIVERSITY · PI SANDERS, CHARLES R · 2006 to 2007
$340k
NIA NIH HHS R21 AG026581NIA NIH HHS R21 AG236581NIGMS NIH HHS 5P41GM066340-05NIGMS NIH HHS P01 GM080513NIGMS NIH HHS P01 GM80513NIGMS NIH HHS P41 GM066340NIGMS NIH HHS T32 GM008320
6 · The paper itself

Abstract

The amyloid precursor protein (APP) is subject to alternative pathways of proteolytic processing, leading either to production of the amyloid-beta (Abeta) peptides or to non-amyloidogenic fragments. Here, we report the first structural study of C99, the 99-residue transmembrane C-terminal domain of APP liberated by beta-secretase cleavage. We also show that cholesterol, an agent that promotes the amyloidogenic pathway, specifically binds to this protein. C99 was purified into model membranes where it was observed to homodimerize. NMR data show that the transmembrane domain of C99 is an alpha-helix that is flanked on both sides by mostly disordered extramembrane domains, with two exceptions. First, there is a short extracellular surface-associated helix located just after the site of alpha-secretase cleavage that helps to organize the connecting loop to the transmembrane domain, which is known to be essential for Abeta production. Second, there is a surface-associated helix located at the cytosolic C-terminus, adjacent to the YENPTY motif that plays critical roles in APP trafficking and protein-protein interactions. Cholesterol was seen to participate in saturable interactions with C99 that are centered at the critical loop connecting the extracellular helix to the transmembrane domain. Binding of cholesterol to C99 and, most likely, to APP may be critical for the trafficking of these proteins to cholesterol-rich membrane domains, which leads to cleavage by beta- and gamma-secretase and resulting amyloid-beta production. It is proposed that APP may serve as a cellular cholesterol sensor that is linked to mechanisms for suppressing cellular cholesterol uptake.

Indexed as

Membranes, ArtificialModels, ChemicalAmino Acid MotifsAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesCholesterolDimerizationHumansPeptidesProtein Processing, Post-TranslationalProtein Structure, TertiaryProtein TransportAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesCholesterolMembranes, ArtificialPeptides

Identifiers

PMID18702528
PMCPMC2572687
OpenAlexW2050586736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.